Atlas Trials

Efficacy and Safety Of Alirocumab to Prevent Early Cardiac Allograft Vasculopathy in Recent Heart Transplant Recipients

Clinical trial NCT04193306 · UNKNOWN

Trial details

NCT number
NCT04193306
Sponsor
Institute for Clinical and Experimental Medicine
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Cardiac Allograft Vasculopathy
Start date
2019-11-18
Primary completion
2025-05-01
Enrollment
126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.